Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Further Studies on Triazinoindoles as Potential Novel Multitarget-Directed Anti-Alzheimer’s Agents
Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 21, pp. 3557-3574
Closed Access | Times Cited: 23

Showing 23 citing articles:

In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
Divya Teli, Mamta B. Shah, Mahesh T. Chhabria
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 126
Pivotal role of nitrogen heterocycles in Alzheimer’s disease drug discovery
Shikha Kumari, Maddeboina Krishnaiah, Rinda Devi Bachu, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103322-103322
Open Access | Times Cited: 35
Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease
Nissi Sharon, Vinod G. Ugale, Pannala Padmaja, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 379-396
Closed Access | Times Cited: 4
Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease
Xin Lü, Yueqing Li, Qianwen Guan, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 6, pp. 1135-1156
Closed Access | Times Cited: 3
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 15
Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 7
Novel alkyl-substituted 4-methoxy benzaldehyde thiosemicarbazones: Multi-target directed ligands for the treatment of Alzheimer's disease
Mokshada E. Varma, Vinod G. Ugale, Javeria Shaukat, et al.
European Journal of Pharmacology (2023) Vol. 957, pp. 176028-176028
Closed Access | Times Cited: 5
Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer’s Disease
Lilesh Kumar Pradhan, Pradyumna Kumar Sahoo, Santosh Chauhan, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 6, pp. 1143-1165
Closed Access | Times Cited: 9
Novel Coumarin–Pyridine Hybrids as Potent Multi-Target Directed Ligands Aiming at Symptoms of Alzheimer’s Disease
Elaheh Babaei, Tuba Tüylü Küçükkılınç, Leili Jalili‐Baleh, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 9
Novel pyrrolidine-alkylamino-substituted dicyanoisophorone derivatives as near-infrared fluorescence probe for imaging β-amyloid in vitro and in vivo
Hui Zhou, Jihang Zhai, Huiyuan Gong, et al.
Analytica Chimica Acta (2024) Vol. 1317, pp. 342894-342894
Closed Access | Times Cited: 1
Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer’s agents: design, synthesis and biological evaluation
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
Carbazole-based semicarbazones and hydrazones as multifunctional anti-Alzheimer agents
Kishan B. Patel, Dushyant V. Patel, Nirav R. Patel, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10278-10299
Open Access | Times Cited: 12
Role of Computational Modeling in Drug Discovery for Alzheimer’s Disease
Mange Ram Yadav, Prashant R. Murumkar, Rahul Barot, et al.
Challenges and advances in computational chemistry and physics (2023), pp. 57-107
Closed Access | Times Cited: 3
Anti‐Epileptic Drug‐Lipid Conjugates for Delivery to the Brain: In Silico ADMET Prediction, Molecular Docking and Molecular Dynamics Simulations
Mansi Athalye, Divya Teli, Abhilasha Sharma, et al.
ChemistrySelect (2023) Vol. 8, Iss. 34
Closed Access | Times Cited: 3
Triazines, Tetrazines, and Fused Ring Polyaza Systems
Marie‐Aude Hiebel, Franck Suzenet
Progress in heterocyclic chemistry (2019), pp. 505-531
Closed Access | Times Cited: 7
Recent Advancements in the Treatment of Alzheimer’s Disease: A Multitarget-directed Ligand Approach
Sumit Kumar, Amol T. Mahajan, Ramesh Ambatwar, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 37, pp. 6032-6062
Closed Access | Times Cited: 2
Unveiling Piperazine-Quinoline Hybrids as Potential Multi-Target Directed Anti- Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
Afzal Nagani, Moksh Shah, Salman Patel, et al.
Research Square (Research Square) (2024)
Open Access
Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease
Mohamed Elsawalhy, Adel A.‐H. Abdel‐Rahman, Ebtesam A. Basiony, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1407-1407
Open Access
Efficient Synthesis of Promising Antidiabetic Triazinoindole Analogues via Solvent-Free Method: Investigating the Reaction of 1,3-Diketones and 2,5-Dihydro-3H-[1,2,4]triazino[5,6-b]indole-3-thione
Ranjana Aggarwal, Prince Kumar, Mona Hooda, et al.
Organic & Biomolecular Chemistry (2024)
Closed Access
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance
Ornella Randazzo, Stella Cascioferro, Camilla Pecoraro, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 4
Triazines, tetrazines, and fused ring polyaza systems
Marie‐Aude Hiebel, Franck Suzenet
Progress in heterocyclic chemistry (2021), pp. 441-472
Closed Access | Times Cited: 3
A Mini-Review on the Synthesis of Substituted Isatins: From Early Approaches to Recent Advances with a Specific Focus on Sulfamoyl and Amino Derivatives
Asu Büşra Temizer, Taha Koulani, Özge Soylu‐Eter, et al.
Mini-Reviews in Organic Chemistry (2022) Vol. 21, Iss. 1, pp. 58-72
Closed Access | Times Cited: 1
ANTICANCER ACTIVITY OF ISATIN - PHENYLACETAMIDE MOLECULAR HYBRIDS: SYNTHESIS AND CHARACTERIZATION
Beula Sj, Tumuluru Rr
International Journal of Biology Pharmacy and Allied Sciences (2022) Vol. 11, Iss. 4
Open Access
Page 1

Scroll to top